BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30064156)

  • 1. Visceral adiposity index as a useful tool for the assessment of cardiometabolic disease risk in women aged 65 to 74.
    Dereziński T; Zozulińska-Ziółkiewicz D; Uruska A; Dąbrowski M
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3052. PubMed ID: 30064156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects.
    Maddaloni E; Cavallari I; De Pascalis M; Keenan H; Park K; Manfrini S; Buzzetti R; Patti G; Di Sciascio G; Pozzilli P
    Am J Cardiol; 2016 Sep; 118(6):822-827. PubMed ID: 27457430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS).
    Vizzuso S; Del Torto A; Dilillo D; Calcaterra V; Di Profio E; Leone A; Gilardini L; Bertoli S; Battezzati A; Zuccotti GV; Verduci E
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus.
    Randrianarisoa E; Lehn-Stefan A; Hieronimus A; Rietig R; Fritsche A; Machann J; Balletshofer B; Häring HU; Stefan N; Rittig K
    J Atheroscler Thromb; 2019 Sep; 26(9):821-834. PubMed ID: 30787215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral Adiposity Index Score is the Better Predictor of Clinical and Coronary Angiographic Severity Assessment than Other Adiposity Indices in Patients with Acute Coronary Syndrome.
    Biswas E; Choudhury AK; Amin MR; Khalequzzaman M; Chowdhury S; Kabir FI; Sakib MM; Mahabub EE; Singha CK
    Mymensingh Med J; 2019 Apr; 28(2):382-388. PubMed ID: 31086155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Visceral Adiposity Index and Anthropometry to Identify Preclinical Atherosclerosis in Menopausal Status Women.
    Tongdee P; Loyd RA; Winwan K; Nimkuntod P
    J Med Assoc Thai; 2016 Oct; 99 Suppl 7():S30-5. PubMed ID: 29901383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population.
    Amato MC; Giordano C; Pitrone M; Galluzzo A
    Lipids Health Dis; 2011 Oct; 10():183. PubMed ID: 22011564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and validation of a new visceral adiposity index for predicting visceral obesity and cardiometabolic risk in a Korean population.
    Oh SK; Cho AR; Kwon YJ; Lee HS; Lee JW
    PLoS One; 2018; 13(9):e0203787. PubMed ID: 30212516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA study.
    Kouli GM; Panagiotakos DB; Kyrou I; Georgousopoulou EN; Chrysohoou C; Tsigos C; Tousoulis D; Pitsavos C
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):881-889. PubMed ID: 28851556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
    Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
    Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Visceral Adiposity Index Serve as a Simple Tool for Identifying Individuals with Insulin Resistance in Daily Clinical Practice?
    Štěpánek L; Horáková D; Cibičková Ľ; Vaverková H; Karásek D; Nakládalová M; Zapletalová J
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470593
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity of various adiposity indices in identifying cardiometabolic diseases in Arab adults.
    Al-Daghri NM; Al-Attas OS; Wani K; Alnaami AM; Sabico S; Al-Ajlan A; Chrousos GP; Alokail MS
    Cardiovasc Diabetol; 2015 Aug; 14():101. PubMed ID: 26249167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUITABILITY OF VISCERAL ADIPOSITY INDEX AS A MARKER FOR CARDIOMETABOLIC RISKS IN JORDANIAN ADULTS.
    Numan Ahmad M; Halim Haddad F
    Nutr Hosp; 2015 Dec; 32(6):2701-9. PubMed ID: 26667723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Visceral Adiposity Index with Visceral Fat in Obese Patients with and without Type 2 Diabetes Mellitus.
    Kalapur S; Singh C
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominal visceral fat measurement using dual-energy X-ray: association with cardiometabolic risk factors.
    Rothney MP; Catapano AL; Xia J; Wacker WK; Tidone C; Grigore L; Xia Y; Ergun DL
    Obesity (Silver Spring); 2013 Sep; 21(9):1798-802. PubMed ID: 23696250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in China.
    Chen C; Xu Y; Guo ZR; Yang J; Wu M; Hu XS
    Lipids Health Dis; 2014 Jul; 13():108. PubMed ID: 25002013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglycerides and waist to height ratio are more accurate than visceral adiposity and body adiposity index to predict impaired fasting glucose.
    Elizalde-Barrera CI; Rubio-Guerra AF; Lozano-Nuevo JJ; Olvera-Gomez JL
    Diabetes Res Clin Pract; 2019 Jul; 153():49-54. PubMed ID: 31132383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference.
    Wan H; Wang Y; Xiang Q; Fang S; Chen Y; Chen C; Zhang W; Zhang H; Xia F; Wang N; Lu Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):118. PubMed ID: 32736628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
    Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
    Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.